Rush to Buy Merck’s Covid Pill Risks Leaving Poor Countries Behind

October 12, 2021 |
‘Entirely unsurprising’: Merck slammed for 4,000% markup of taxpayer-funded COVID-19 drug
‘Therapeutics Nationalism’? Poor at Risk of Being Left Behind as Rich Buy Up New Covid Drug
Related Posts
Access to Medicines

Pharma’s alleged “brea...
PEPFAR Watch

PEPFAR is Rolling the Cloc...
Access to Medicines

Pharma Pricing Secrecy Run...